ExodusPoint Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$220K Buy
2022
Q4
Sell
2022
Q3
$1.1M Buy
2022
Q2
$347K Buy
2020
Q2
Sell
2020
Q1
$964K Buy
2019
Q4
$458K Buy